Table A1.

Measure Specifications

Measure	Eligible Patients (denominator)	Patient Goal (numerator)	Similar To
Antithrombotic therapy	Patients 18+ years with ischemic vascular disease or 40+ with diabetes	Taking aspirin or other antithrombotic therapy	National Quality Forum (NQF) 0631
Blood pressure control	Patients 18–75 years with hypertension with or without diabetes	Without diabetes: Systolic <140 mmHg, Diastolic <90 mmHg With diabetes: Systolic <130 mmHg, Diastolic <80 mmHg	NQF 0018 NQF 0013
Body mass index recorded	Patients 18+ years	BMI recorded in past 24 months	NQF 1690
Cholesterol testing	General population: Male (35+ years) or female (45+) patients with no prior diagnosis High risk: Patients 18–75 with dyslipidemia and (IVD or diabetes)	General population: Total cholesterol and/or Low Density Lipids (LDL) tested in the past 5 years High risk: LDL tested in the past 12 months	NQF 0064 (DM); 0074 (IVD/CAD)
Cholesterol control	General population: Male (35+ years) or female (45+) patients with no prior diagnosis and total cholesterol and/ or Low Density Lipids (LDL) tested in the past 5 years High risk: Patients 18–75 with dyslipidemia and (IVD or diabetes) and LDL tested in the past 12 months	General population: LDL <160 mg/ dL or total cholesterol <240 mg/dL High risk: LDL<100 mg/dL	NQF 0064 (DM); 0074 (IVD/CAD)
HbA1c control	Patients 18–75 years with diabetes and hemoglobin A1c tested in the past 6 months	HbA1c level <7%
HbA1c testing	Patients 18–75 years with diabetes	HbA1c test recorded in the past 6 months	NQF 0057
Smoking cessation intervention	Patients 18+ years with a “current smoker” smoking status	Smoking cessation intervention (Rx or counseling) received in the past 12 months	NQF 0028B
Smoking status recorded	Patients 18+ years	Smoking status recorded in the past 12 months	NQF 0028A